TG Therapeutics, Inc.

TG Therapeutics, Inc.verified

TGTX

Price:

$16.55

Market Cap:

$2.56B

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand...[Read more]

Industry

Biotechnology

IPO Date

2010-05-03

Stock Exchange

NASDAQ

Ticker

TGTX

The ROE as of June 2024 (TTM) for TG Therapeutics, Inc. (TGTX) is -5.90%

According to TG Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -5.90%. This represents a change of 16.16% compared to the average of -5.08% of the last 4 quarters.

TG Therapeutics, Inc. (TGTX) Historical ROE (quarterly & annually)

How has TGTX ROE performed in the past?

The mean historical ROE of TG Therapeutics, Inc. over the last ten years is -122.99%. The current -5.90% ROE has changed -95.20% with respect to the historical average. Over the past ten years (40 quarters), TGTX's ROE was at its highest in in the March 2020 quarter at 3.78%. The ROE was at its lowest in in the June 2019 quarter at -274.24%.

Quarterly (TTM)
Annual

Average

-122.99%

Median

-58.51%

Minimum

-721.76%

Maximum

26.76%

TG Therapeutics, Inc. (TGTX) ROE by Quarter and Year

Discovering the peaks and valleys of TG Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 308.12%

Maximum Annual ROE = 26.76%

Minimum Annual Increase = -315.22%

Minimum Annual ROE = -721.76%

Quarterly (TTM)
Annual
YearROEChange
20237.90%-40.85%
202213.35%-50.12%
202126.76%-148.61%
2020-55.05%-315.22%
201925.58%-103.54%
2018-721.76%308.12%
2017-176.85%-18.94%
2016-218.17%252.04%
2015-61.97%-11.01%
2014-69.64%36.21%

TG Therapeutics, Inc. (TGTX) Average ROE

How has TGTX ROE performed in the past?

The current ROE of TG Therapeutics, Inc. (TGTX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

16.00%

5-year avg

3.71%

10-year avg

-122.99%

TG Therapeutics, Inc. (TGTX) ROE vs. Peers

How is TGTX’s ROE compared to its peers?

TG Therapeutics, Inc.’s ROE is greater than Madrigal Pharmaceuticals, Inc. (-128.60%), greater than Intercept Pharmaceuticals, Inc. (-78.24%), greater than Terns Pharmaceuticals, Inc. (-35.55%), greater than Hepion Pharmaceuticals, Inc. (-268.74%), less than Exelixis, Inc. (8.85%), greater than Viking Therapeutics, Inc. (-18.41%), less than BioXcel Therapeutics, Inc. (374.17%), greater than Akero Therapeutics, Inc. (-27.78%), less than Reata Pharmaceuticals, Inc. (19.32%), greater than X4 Pharmaceuticals, Inc. (-275.36%), greater than PDS Biotechnology Corporation (-145.99%),

Build a custom stock screener for TG Therapeutics, Inc. (TGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TG Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TG Therapeutics, Inc. (TGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TG Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is TG Therapeutics, Inc.'s ROE?

How is the ROE calculated for TG Therapeutics, Inc. (TGTX)?

What is the highest ROE for TG Therapeutics, Inc. (TGTX)?

What is the 3-year average ROE for TG Therapeutics, Inc. (TGTX)?

What is the 5-year average ROE for TG Therapeutics, Inc. (TGTX)?

How does the current ROE for TG Therapeutics, Inc. (TGTX) compare to its historical average?